US5264578A
(en)
|
1987-03-20 |
1993-11-23 |
Allergan, Inc. |
Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
|
US5602130A
(en)
*
|
1987-03-20 |
1997-02-11 |
Allergan |
Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
|
CA2017956A1
(fr)
*
|
1989-07-06 |
1991-01-06 |
Werner Bollag |
Utilisation de retinoides
|
US5183827A
(en)
*
|
1989-09-19 |
1993-02-02 |
Allergan, Inc. |
Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
|
US5272156A
(en)
*
|
1989-09-19 |
1993-12-21 |
Allergan, Inc. |
Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
|
US5264456A
(en)
*
|
1989-12-29 |
1993-11-23 |
Allergan, Inc. |
Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity
|
US5324840A
(en)
*
|
1992-06-11 |
1994-06-28 |
Allergan, Inc. |
Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
|
US6172115B1
(en)
|
1993-02-11 |
2001-01-09 |
Allergan Sales, Inc. |
Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
|
US5455265A
(en)
|
1993-02-11 |
1995-10-03 |
Allergan, Inc. |
Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
|
US5475022A
(en)
*
|
1993-10-18 |
1995-12-12 |
Allergan, Inc. |
Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
|
US5426118A
(en)
*
|
1993-12-30 |
1995-06-20 |
Allergan, Inc. |
[4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity
|
US5498755A
(en)
*
|
1994-08-23 |
1996-03-12 |
Chandraratna; Roshantha A. |
Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
|
US5618931A
(en)
*
|
1994-12-29 |
1997-04-08 |
Allergan |
Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5618943A
(en)
*
|
1994-12-29 |
1997-04-08 |
Allergan |
Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5543534A
(en)
*
|
1994-12-29 |
1996-08-06 |
Allergan |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
|
US5514825A
(en)
*
|
1994-12-29 |
1996-05-07 |
Allergan, Inc. |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5648514A
(en)
|
1994-12-29 |
1997-07-15 |
Allergan |
Substituted acetylenes having retinoid-like biological activity
|
US5556996A
(en)
*
|
1994-12-29 |
1996-09-17 |
Allergan |
Oxiranyls disubstituted with a phenyl group and a substituted chromanyl or tetrahydroquinolinyl group having retinoid like activity
|
US5489584A
(en)
*
|
1994-12-29 |
1996-02-06 |
Allergan, Inc. |
Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
|
US5599967A
(en)
*
|
1994-12-29 |
1997-02-04 |
Allergan |
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
|
US5534641A
(en)
|
1994-12-29 |
1996-07-09 |
Allergan |
Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
|
US5534261A
(en)
*
|
1995-01-17 |
1996-07-09 |
University Of Southern California |
Retinoid-based compositions and method for preventing adhesion formation using the same
|
US6025388A
(en)
|
1995-04-26 |
2000-02-15 |
Allergan Sales, Inc. |
Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
|
US5616712A
(en)
*
|
1995-05-16 |
1997-04-01 |
Allergan |
Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity
|
US5675033A
(en)
*
|
1995-06-06 |
1997-10-07 |
Allergan |
2,4-pentadienoic acid derivatives having retinoid-like biological activity
|
US5917082A
(en)
|
1995-06-06 |
1999-06-29 |
Allergan Sales, Inc. |
2,4-pentadienoic acid derivatives having retinoid-like biological activity
|
US5958954A
(en)
|
1995-09-01 |
1999-09-28 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
US5952345A
(en)
|
1995-09-01 |
1999-09-14 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
US6218128B1
(en)
|
1997-09-12 |
2001-04-17 |
Allergan Sales, Inc. |
Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
|
US6008204A
(en)
|
1995-09-01 |
1999-12-28 |
Allergan Sales, Inc. |
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
|
AU7598596A
(en)
*
|
1995-11-01 |
1997-05-22 |
Allergan, Inc. |
Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
|
US5675024A
(en)
|
1995-11-22 |
1997-10-07 |
Allergan |
Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
|
US5663357A
(en)
|
1995-11-22 |
1997-09-02 |
Allergan |
Substituted heteroarylamides having retinoid-like biological activity
|
US5965606A
(en)
|
1995-12-29 |
1999-10-12 |
Allergan Sales, Inc. |
Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
|
US5688957A
(en)
*
|
1995-12-29 |
1997-11-18 |
Allergan |
(3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
|
US5808124A
(en)
*
|
1996-06-21 |
1998-09-15 |
Allergan |
O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
US5723666A
(en)
*
|
1996-06-21 |
1998-03-03 |
Allergan |
Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
US6555690B2
(en)
|
1996-06-21 |
2003-04-29 |
Allergan, Inc. |
Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
US5741896A
(en)
*
|
1996-06-21 |
1998-04-21 |
Allergan |
O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
US5763635A
(en)
*
|
1996-06-21 |
1998-06-09 |
Allergan |
Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity
|
US5773594A
(en)
|
1996-06-21 |
1998-06-30 |
Allergan |
Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
|
US5747542A
(en)
*
|
1996-06-21 |
1998-05-05 |
Allergan |
Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity
|
US5739338A
(en)
*
|
1996-11-05 |
1998-04-14 |
Allergan |
N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
|
US5728846A
(en)
|
1996-12-12 |
1998-03-17 |
Allergan |
Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
|
US5760276A
(en)
|
1997-03-06 |
1998-06-02 |
Allergan |
Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
|
US6037488A
(en)
|
1997-04-19 |
2000-03-14 |
Allergan Sales, Inc. |
Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
|
US5919970A
(en)
|
1997-04-24 |
1999-07-06 |
Allergan Sales, Inc. |
Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
|
US6313107B1
(en)
|
2000-08-29 |
2001-11-06 |
Allergan Sales, Inc. |
Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
|
US6380256B1
(en)
|
2000-08-29 |
2002-04-30 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|
US6369225B1
(en)
|
2000-08-29 |
2002-04-09 |
Allergan Sales, Inc. |
Compounds having activity as inhibitors of cytochrome P450RAI
|